|
|
|
|
Science Sparks @ ACTREC
|
 29 May 2023 |
Vol. No. 12; Issue No. 580 |
|
|
Publications
|
|
1. Verghese G, Li M, Liu F, Lohan A, Kurian NC, Meena S, Gazinska P, Shah A, Oozeer A, Chan T, Opdam M, Linn S, Gillett C, Alberts E, Hardiman T, Jones S, Thavaraj S, Jones JL, Salgado R, Pinder SE, Rane S, Sethi A, Grigoriadis A (2023). Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large-scale studies. Journal of Pathology.
2. D'Silva SZ, Singh M, Pinto AS (2023). NK cell defects: implication in acute myeloid leukemia. Frontiers in Immunology. 14: 1112059.
3. Inchanalkar M, Srivatsa S, Ambatipudi S, Bhosale PG, Patil A, Schäffer AA, Beerenwinkel N, Mahimkar MB (2023). Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers. Clinical Epigenetics. 15(1): 93.
|
|
|
|
|
|
|
Legends of Science
|
|
Harprasad Chaudhuri
Harprasad Chaudhuri obtained his PhD from the University of London in 1922. He specialized in plant pathology. He studied the various diseases of tea bushes, orchards and vegetable crops and the effect of X-rays and ultraviolet rays on the physiology of some fungi. His research areas included soil, aquatic and coprophilous fungi, slime moulds, and bacteria, including wheat and mycorrhiza bacterial diseases. Dr. Chaudhuri was a Fellow of the Indian Botanical Society and Botanical Society of Bengal. He also was the President of the Botany Section of the Indian Science Congress in 1932.
|
|
| |
|
Jnanendra Chandra Ghosh
Jnanendra Chandra Ghosh obtained his DSc degree from the University of Kolkata in 1918. He did pioneering research on getting liquid fuel from carbon monoxide and hydrogen and the step-wise mechanism of ammonia synthesis from its elements. He introduced several subjects for study, including power engineering and fermentation technology. Dr. Ghosh was a member of the Royal Society of Empire, London, and Indian Scientific Mission to the UK, USA and Canada. He was President of INSA (1943-1944).
|
|
| |
|
|
|
|
Do You Know?
In 1986, FDA approved the first immunotherapy drug, alfa-interferon, to treat rare, hairy cell leukemia.
|
|
|
|
|
|
2023 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
